Obesity Rate Declining in U.S.

Gallup: After peaking at a record high of 39.9% in 2022, the U.S. adult obesity rate has gradually declined to 37.0% in 2025. This is a statistically meaningful decrease representing an estimated 7.6 million fewer obese adults compared with three years ago. Meanwhile, diagnoses of diabetes -- a lifetime disease that can be managed but not cured -- have now reached an all-time high of 13.8%. Both metrics are part of the ongoing Gallup National Health and Well-Being Index.

Over the past year, more Americans have turned to Type 2 antidiabetic GLP-1 drugs such as semaglutide (brand names Ozempic and Wegovy) for weight loss purposes. The percentage of adults who report taking this class of medicine specifically for weight loss has increased to 12.4%, compared with 5.8% in February 2024 when Gallup first measured it. Usage among women (15.2%) continues to outpace men (9.7%), but both groups have more than doubled their use in the past year. These results dovetail with increased awareness of the drugs used for weight loss, which has risen from 80% to 89% nationally in the same period.

Read more of this story at Slashdot.